NHS to lose out on new drugs, pharma firm Novartis warns
Pritti MistryBusiness reporter, BBC News PA Media NHS patients will lose access to new cutting-edge treatments because of skyrocketing costs, the pharmaceutical giant Novartis has claimed amid a row over drug pricing deals. The warning comes after talks over the cost of medicines for the UK between Health Secretary Wes Streeting and pharma firms broke … Read more